Rapamycin bei Mäusen und Menschen: Lebensspanne, Immunwirkungen und Studiengrenzen

Rapamycin for Longevity: The mTOR Inhibitor That Extends Lifespan in Mice—But Might Suppress Your Immune System Rapamycin is the most promising longevity drug nobody can agree on. In this episode of Biological Age Decoded: HRV, Heart Rate and Longevity Science, we separate mouse data from human reality and break down the mTOR inhibitor that extends lifespan in animals, is now being tested in humans, and whose immune effects are both the promise and the problem. Rapamycin and rapamycin analogs (rapalogs) in aging and age-related disease: mechanisms, animal evidence, and emerging human data. Search queries this episode answers: rapamycin longevity, does rapamycin extend lifespan, rapamycin human trials, rapamycin side effects, mTOR aging, should I take rapamycin. Key clinical questions covered: • Mechanism: How rapamycin inhibits mTOR (mechanistic target of rapamycin)—the central nutrient-sensing pathway regulating cell growth, autophagy, and protein synthesis—and why caloric restriction, fasting, and rapamycin converge on the same pathway. • Measurement: How mTOR inhibition is measured in humans through downstream markers like p70S6K phosphorylation, autophagy flux, and immune cell function—and why there is no simple blood test for "mTOR activity." • Trial outcomes: What animal and human evidence shows. Rapamycin extends lifespan in mice, even when started late in life. The PEARL trial (Participatory Evaluation of Aging with Rapamycin for Longevity) is one of the first randomized human trials, and results have been mixed—with signals for improved immune function and reduced infections, but also concerns about insulin resistance and immune suppression. The evidence is not yet sufficient to recommend rapamycin for general longevity use. • Clinical application: How transplant medicine has used rapamycin for decades as an immunosuppressant, and why longevity dosing (intermittent, low-dose) is fundamentally different from transplant dosing (daily, high-dose). • Patient action: How to think about rapamycin risk-benefit if you are considering it, what monitoring is required, and why the absence of long-term human safety data is the main reason most clinicians hesitate. Resources & Links (full URLs visible for copy/paste): 📱 Heart rate and HRV tracking app—monitor resting heart rate and HRV as general markers of physiological state while exploring longevity interventions: https://play.google.com/store/apps/details?id=com.flycode.bloodpressure 💬 Telegram longevity community—discuss rapamycin protocols, side effects, and monitoring with others navigating the same decisions: https://t.me/stopbioage 🩻 Free AI health explanations—enter your labs (glucose, insulin, immune markers) for educational context about mTOR-related pathways: https://aidevmd.com/ 📚 PubMed clinical trials—read the PEARL trial results and the mouse lifespan studies directly: https://pubmed.gov Disclaimer: Educational only. Not medical advice. Rapamycin is a prescription drug with serious potential side effects. Do not use it without medical supervision.